Condition
Statin Therapy
Total Trials
5
Recruiting
3
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 4 (2)
Trial Status
Recruiting3
Unknown1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06684106Not ApplicableRecruiting
Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance
NCT06603363Not ApplicableRecruiting
Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT
NCT06804980Phase 4RecruitingPrimary
DESIFOR-EXPAND (MHIF)
NCT01509014Not ApplicableUnknownPrimary
Community Pharmacy Assisting in Total Cardiovascular Health
NCT00113477Phase 4CompletedPrimary
The Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy
Showing all 5 trials